Presolicitation
BPA Call Order for Clinical Chemistry & Immunoassay Reagents
W81K0224F0060
Department of the Army, W40M Mrco Pacific. In-Vitro Diagnostic Substance Manufacturing.
Awarded
$165,000.00 obligated so far on USAspending
Description
As published on SAM.gov.
The Medical Readiness Contracting Office – Pacific intends to issue a bulk-funded BPA call to Abbott Laboratories Inc. for Clinical Chemistry and Immunoassay reagents for May 2024 for Tripler Army Medical Center, Hawaii.
The statutory authority permitting this award without providing full and open competition is FAR 13.106-1(b)(1)(i), which authorizes the Government to award contracts when the circumstances of the contract action deem only one reasonably available and no other suppliers or services will satisfy agency requirements. This announcement fulfills the synopsis requirement under FAR 5.201 and 5.203. This Notice of Intent is not a request for competitive quotes.
Information received in response to this notice will be considered solely for the purpose of determining whether a competitive procurement is in the best interest of the Government.
Disclaimer and Important Notes: This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to supply the required products. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. No proprietary, classified, confidential, or sensitive information should be included in your response.
The contract, on USAspending
Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.
- Recipient
- Abbott Laboratories Inc.
- UEI
- NH3LDK8CFAK7
- CAGE
- 33110
- Vendor location
- Abbott Park, IL
- Contract
- W81K0224F0060 under W81K0224A0005, bpa call
- Obligated
- $165,000.00
- Actions
- 1 between April 30, 2024 and April 30, 2024
- Competition
- Not Competed Under SAP, 1 offer received
- Set-aside reported
- No Set Aside Used.
- Described as
- Bulk-Funded BPA Call: Clinical Chemistry & Immunoassay Tests, 1-31 May 2024.
- Match
- solicitation number W81K0224F0060 was reused as the contract number; same awarding office W81K02 (high confidence)
- Record
- USAspending award page
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
April 26, 2024
Presolicitation
Due May 3, 2024 at 4:00 PM EDT. SAM.gov, notice 7680a2e239114913b565598d879fcc48
Points of contact
- Megumi Kuwadamegumi.kuwada.civ@health.mil8084339489